Key prognostic elements to consider in sarcoidosis patients who contract COVID-19 pneumonia are pulmonary involvement, the underlying immune system dysfunction, immunosuppressive therapies' use, and the increased risk for hypercoagulability.
Keywords: COVID‐19 pneumonia; chest ct; ground‐glass; mediastinal lymphadenopathy; sarcoidosis.
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.